Britain鈥檚 biotech firms now have a code of conduct designed to prevent them
from overhyping the progress of experimental drugs. Published this week by the
BioIndustry Association (BIA), the code was drafted in the wake of a damaging
scandal last year
(This Week, 4 July 1998, p 20).
From now on, companies must
have their scientific and clinical progress audited by external experts. Failure
to comply could mean expulsion from the BIA.
More from New 女生小视频
Explore the latest news, articles and features
Health
Personalised cancer vaccine expected to be approved next year
News
Technology
Brazil presidential election dogged by alleged bias by Meta AI tools
News
Health
Body temperature may drive the higher risk of autoimmune conditions in women
News
Comment
Emily St. John Mandel: ‘I don’t want to write something relentlessly bleak’
Culture
Popular articles
Trending New 女生小视频 articles